Korsana Biosciences, Inc.
KRSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001755237
No open-market purchases or sales by Korsana Biosciences, Inc. insiders were filed in the last 90 days; 21 institutions reported holding it in 13F filings for Q2 2026, worth $11.2M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Korsana Biosciences, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 17 | 17 | 0 |
| Shares | 362.8K | 258.8K | −104.0K (−28.7%) |
| Value | $1.06M | $595.4K | −$460.5K (−43.6%) |
New holders (3)
Institutions that held Korsana Biosciences, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| DRW Securities, LLC | 43,617 | $100.3K | 0.01% |
| Two Sigma Investments, LP | 13,293 | $30.6K | 0.00% |
| Barclays PLC | 5 | $12 | 0.00% |
Sold out (3)
Institutions that held Korsana Biosciences, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Tyndall Capital Partners L P | 155,187 | $451.6K |
| SBI Securities Co., Ltd. | 11 | $32 |
| Pandora Wealth, Inc. | 11 | $32 |